Marshall Wace LLP Increases Stock Holdings in Dolby Laboratories, Inc. (NYSE:DLB)

Marshall Wace LLP increased its position in Dolby Laboratories, Inc. (NYSE:DLB - Free Report) by 50.8% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 112,426 shares of the electronics maker's stock after acquiring an additional 37,870 shares during the quarter. Marshall Wace LLP owned about 0.12% of Dolby Laboratories worth $8,780,000 at the end of the most recent quarter.

Other hedge funds also recently bought and sold shares of the company. Savant Capital LLC boosted its position in shares of Dolby Laboratories by 2.0% during the 4th quarter. Savant Capital LLC now owns 6,274 shares of the electronics maker's stock valued at $490,000 after acquiring an additional 125 shares during the last quarter. Orion Portfolio Solutions LLC raised its stake in Dolby Laboratories by 0.7% in the fourth quarter. Orion Portfolio Solutions LLC now owns 19,522 shares of the electronics maker's stock valued at $1,525,000 after purchasing an additional 132 shares in the last quarter. Harbor Capital Advisors Inc. grew its stake in Dolby Laboratories by 5.6% in the 4th quarter. Harbor Capital Advisors Inc. now owns 2,571 shares of the electronics maker's stock worth $201,000 after buying an additional 136 shares in the last quarter. Mather Group LLC. grew its stake in Dolby Laboratories by 36.8% in the 4th quarter. Mather Group LLC. now owns 528 shares of the electronics maker's stock worth $41,000 after buying an additional 142 shares in the last quarter. Finally, Naples Global Advisors LLC raised its position in shares of Dolby Laboratories by 0.4% during the 4th quarter. Naples Global Advisors LLC now owns 35,730 shares of the electronics maker's stock valued at $2,791,000 after buying an additional 160 shares in the last quarter. Hedge funds and other institutional investors own 58.56% of the company's stock.

Dolby Laboratories Stock Up 2.9 %

Shares of NYSE:DLB opened at $72.75 on Wednesday. The company's fifty day moving average is $78.86 and its 200 day moving average is $78.24. Dolby Laboratories, Inc. has a 52 week low of $66.35 and a 52 week high of $89.66. The stock has a market cap of $6.94 billion, a PE ratio of 26.75 and a beta of 0.94.

Dolby Laboratories Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Wednesday, February 19th. Stockholders of record on Tuesday, February 11th were paid a $0.33 dividend. This represents a $1.32 dividend on an annualized basis and a dividend yield of 1.81%. The ex-dividend date was Tuesday, February 11th. Dolby Laboratories's dividend payout ratio (DPR) is presently 48.53%.

Analyst Upgrades and Downgrades

DLB has been the subject of several research reports. Rosenblatt Securities reiterated a "buy" rating and issued a $100.00 target price on shares of Dolby Laboratories in a research report on Thursday, January 30th. StockNews.com lowered Dolby Laboratories from a "strong-buy" rating to a "buy" rating in a research report on Friday, January 31st. Finally, Barrington Research restated an "outperform" rating and issued a $100.00 target price on shares of Dolby Laboratories in a research report on Thursday, February 13th.

Insider Activity at Dolby Laboratories

In other news, EVP Mark Andrew Sherman sold 40,000 shares of the stock in a transaction that occurred on Thursday, January 30th. The stock was sold at an average price of $84.88, for a total transaction of $3,395,200.00. Following the completion of the sale, the executive vice president now owns 62,397 shares of the company's stock, valued at approximately $5,296,257.36. This represents a 39.06 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CAO Ryan Nicholson sold 7,000 shares of the firm's stock in a transaction that occurred on Wednesday, February 5th. The stock was sold at an average price of $84.07, for a total transaction of $588,490.00. Following the completion of the transaction, the chief accounting officer now owns 29,758 shares in the company, valued at $2,501,755.06. This represents a 19.04 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 65,121 shares of company stock worth $5,501,324 in the last ninety days. 38.39% of the stock is owned by company insiders.

About Dolby Laboratories

Dolby Laboratories, Inc creates audio and imaging technologies that transform entertainment at the cinema, DTV transmissions and devices, mobile devices, OTT video and music services, home entertainment devices, and automobiles. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for a range of media applications; AVC, a digital video codec with high bandwidth efficiency used in various media devices; Dolby AC-4, a digital audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for cinema and various media devices.

Want to see what other hedge funds are holding DLB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Dolby Laboratories, Inc. (NYSE:DLB - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.